Compounds > 1,3,5-triaza-7-phosphaadamantane
Page last updated: 2024-09-04

1,3,5-triaza-7-phosphaadamantane and platinum

1,3,5-triaza-7-phosphaadamantane has been researched along with platinum in 4 studies

Compound Research Comparison

Studies
(1,3,5-triaza-7-phosphaadamantane)		Trials
(1,3,5-triaza-7-phosphaadamantane)		Recent Studies (post-2010)
(1,3,5-triaza-7-phosphaadamantane)		Studies
(platinum)		Trials
(platinum)		Recent Studies (post-2010) (platinum)
4403311,4224576,106

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's4 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cerrada, E; Fröhlich, N; Guerrero, E; Koenen, JM; Laguna, M; Lüttenberg, S; Mendía, A; Miranda, S; Mohr, F1
Bergamini, P; Ferretti, V; Fogagnolo, M; Marchi, A; Marvelli, L; Sforza, F1
Bergamini, P; Cortesi, R; Damiani, C; Drechsler, M; Esposito, E; Mariani, P; Marvelli, L; Pagnoni, A; Ravani, L; Sforza, F1
Bergamini, P; Carducci, F; Cortesi, R; Drechsler, M; Esposito, E; Gallerani, E; Gavioli, R; Mariani, P; Marvelli, L; Sguizzato, M1

Other Studies

4 other study(ies) available for 1,3,5-triaza-7-phosphaadamantane and platinum

ArticleYear
trans-thionate derivatives of Pt(II) and Pd(II) with water-soluble phosphane PTA and DAPTA ligands: antiproliferative activity against human ovarian cancer cell lines.
    Inorganic chemistry, 2013, Jun-03, Volume: 52, Issue:11

    Topics: Adamantane; Antineoplastic Agents; Bridged Bicyclo Compounds, Heterocyclic; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; Ligands; Models, Molecular; Molecular Structure; Organometallic Compounds; Organophosphorus Compounds; Palladium; Platinum; Solubility; Structure-Activity Relationship; Sulfhydryl Compounds; Water

2013
Acetylcholine-like and trimethylglycine-like PTA (1,3,5-triaza-7-phosphaadamantane) derivatives for the development of innovative Ru- and Pt-based therapeutic agents.
    Inorganic chemistry, 2014, May-19, Volume: 53, Issue:10

    Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Crystallography, X-Ray; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Humans; K562 Cells; Models, Molecular; Molecular Structure; Organometallic Compounds; Organophosphorus Compounds; Platinum; Ruthenium; Structure-Activity Relationship

2014
Lipid-based nanoparticles containing cationic derivatives of PTA (1,3,5-triaza-7-phosphaadamantane) as innovative vehicle for Pt complexes: Production, characterization and in vitro studies.
    International journal of pharmaceutics, 2015, Aug-15, Volume: 492, Issue:1-2

    Topics: Adamantane; Antineoplastic Agents; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; DNA; Humans; Lipids; Nanoparticles; Organophosphorus Compounds; Platinum

2015
Solid lipid nanoparticles for the delivery of 1,3,5-triaza-7-phosphaadamantane (PTA) platinum (II) carboxylates.
    Materials science & engineering. C, Materials for biological applications, 2017, May-01, Volume: 74

    Topics: Adamantane; Antineoplastic Agents; Carboxylic Acids; Cell Line, Tumor; Cell Proliferation; Coordination Complexes; Drug Carriers; Emulsions; Humans; K562 Cells; Lipids; Magnetic Resonance Spectroscopy; Nanoparticles; Organophosphorus Compounds; Particle Size; Platinum; Stearic Acids

2017